Early and persistent alterations in the expression of interleukin-1α, lnterleukin-1β and tumor necrosis factor a mRNA levels in fibrosis-resistant and sensitive mice after thoracic irradiation

Radiation Research

Volumn 145, Issue 6, 1996, Pages 762-767

  Johnston, Carl J ^a   Piedboeuf, Bruno ^a,b   Rubin, Philip ^a   Williams, Jacqueline P ^a   Baggs, Raymond ^a   Finkelstein, Jacob N ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; FEMALE; IMMUNE RESPONSE; LATENT PERIOD; LUNG FIBROSIS; LUNG INJURY; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CESIUM RADIOISOTOPES; DISEASE SUSCEPTIBILITY; FEMALE; GAMMA RAYS; IMMUNITY, NATURAL; INTERLEUKIN-1; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; PULMONARY FIBROSIS; RNA, MESSENGER; THORAX; TIME FACTORS; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 0029890929     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.2307/3579368     Document Type: Article

References (41)

1. D. G. Hoyt and J. S. Lazo, Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-β precede bleomycin-induced pulmonary fibrosis in mice. J. Pharmacol. Exp. Ther. 246, 765-771 (1988).
2. P-F. Piguet, M. A. Collart, G. E. Grau, Y. Kapanci and P. Vassalli, Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis. J. Exp. Med. 170, 655-663 (1989).
3. P. Rubin, J. N. Finkelstein and D. L. Shapiro, Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblast. Int. J. Radiat. Oncol. Biol. Phys. 24, 93-101 (1992).
4. J. N. Finkelstein, C. J. Johnston, R. Baggs and P. Rubin, Early alterations in extracellular matrix and transforming growth factor β gene expression in mouse lung indicative of late radiation fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 26, 621-631 (1994).
5. J. Sharplin and A. J. Franko, A quantitative histological study of strain-dependent differences in the effects of irradiation on mouse lung during the early phase. Radiat. Res. 119, 1-14 (1989).
6. J. Sharplin and A. J. Franko, A quantitative histological study of strain-dependent differences in the effects of irradiation on mouse lung during the intermediate and late phases. Radiat. Res. 119, 15-31 (1989).
7. C. J. Johnston, B. Piedboeuf, R. Baggs, P. Rubin and J. N. Finkelstein, Differences in correlation of mRNA gene expression in mice sensitive and resistant to radiation-induced pulmonary fibrosis. Radiat. Res. 142, 197-203 (1995).
8. J. E. Coggle, Biological Effects of Radiation. Taylor & Francis, London, 1983.
9. A. R. Lloyd and J. J. Oppenheim, Poly's lament: the neglected role of the polymorphonuclear neutrophil in the afferent limb of the immune response. Immunol. Today 13, 169-172 (1992).
10. B. J. Sugarman, B. B. Aggarwal, P. E. Hass, I. S. Figari, M. A. Palladino, Jr. and H. M. Shepard, Recombinant human tumor necrosis factor-alpha: effects on proliferation of normal and transformed cells in vitro. Science 230, 943-945 (1985).
11. J. M. Dayer, B. Beutler and A. Cerami, Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts. J. Exp. Med. 162, 2163-2168 (1985).
12. J. A. Schmidt, S. B. Mizel, D. Cohen and I. Green, Interleukin 1, a potential regulator of fibroblast proliferation. J. Immunol. 128, 2177-2182 (1982).
13. S. C. Thornton, S. B. Por, B. J. Walsh, R. Penny and S. N. Breit, Interaction of immune and connective tissue cells: I. The effect of lymphokines and monokines on fibroblast growth. J. Leukocyte Biol. 47, 312-320 (1990).
14. A. E. Postlethwaite, L. B. Lachman, C. L. Mainardi and A. H. Kang, Interleukin 1 stimulation of collagenase production by cultured fibroblasts. J. Exp. Med. 157, 801-806 (1983).
15. P-F. Piguet, Is "tumor necrosis factor" the major effector of pulmonary fibrosis? Eur. Cytokine Netw. 1, 257-258 (1990).
16. E. L. Travis, The sequence of histological changes in mouse lung after single doses of x-rays. Int. J. Radiat. Oncol. Biol. Phys. 6, 345-347 (1980).
17. D. Penney, P. Van Houtte, D. W. Siemann, W. A. Rosenkrans, Jr., P. Rubin and R. A. Cooper, Jr., The long term effects of radiation modalities on mouse lung. Scanning Electron Microsc. 221-228 (1986).
18. D. P. Penney, D. W. Siemann, P. Rubin, D. L. Shapiro, J. N. Finkelstein and R. A. Cooper, Jr., Morphologic changes reflecting early and late effects of irradiation of the distal lung of the mouse: a review. Scanning Electron Microsc. 413-425 (1982).
19. J. M. Chirgwin, A. E. Przybyla, R. J. MacDonald and W. J. Rutter, Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299 (1979).
20. H. Lehrach, D. Diamond, J. M. Wozney and H. Boedtker, RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry 16, 4743-4751 (1977).
21. P. S. Thomas, Hybridization of denatured RNA transferred or dotted to nitrocellulose paper. Meth. Enzymol. 100, 255-266 (1983).
22. A. P. Feinberg and B. Vogelstein, A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132, 6-13 (1983).
23. P. Rubin and G. W. Casarett, Clinical Radiation Pathology, Vols. 1 and 2. W. B. Saunders, Philadelphia, 1968.
24. P-F. Piguet, Cytokines involved in pulmonary fibrosis. Int. Rev. Exp. Pathol. 34, 173-181 (1993).
25. R. G. Crystal, P. B. Bitterman, S. I. Rennard, A. J. Hance and B. A. Keogh, Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (First of two parts). New Engl. J. Med. 310, 154-166 (1984).
26. R. G. Crystal, P. B. Bitterman, S. I. Rennard, A. J. Hance and B. A. Keogh, Interstitial lung diseases of unknown cause. Disorders characterized by chronic inflammation of the lower respiratory tract (Second of two parts). New Engl. J. Med. 310, 235-244 (1984).
27. P. Rubin, C. J. Johnston, J. P. Williams, S. McDonald and J. N. Finkelstein, A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int. J. Radiat. Oncol. Biol. Phys. 33, 99-109 (1995).
28. M. S. Anscher, W. P. Peters, H. Reisenbichler, W. P. Petros and R. L. Jirtle, Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. New Engl. J. Med. 328, 1592-1598 (1993).
29. R. K. Scheule, R. C. Perkins, R. Hamilton and A. Holian, Bleomycin stimulation of cytokine secretion by the human alveolar macrophage. Am. J. Physiol. 262, L386-L391 (1992).
30. W. Fiers, Tumor necrosis factor. Characterization at the molecular, cellular and in vivo level. FEBS Lett. 285, 199-212 (1991).
31. P. R. Bachwich, J. P. Lynch, J. Larrick, M. Spengler and S. L. Kunkel, Tumor necrosis factor production by human sarcoid alveolar macrophages. Am. J. Pathol. 125, 421-425 (1986).
32. P-F. Piguet, H. Rosen, C. Vesin and G. E. Grau, Effective treatment of the pulmonary fibrosis elicited in mice by bleomycin or silica with anti-CD-11 antibodies. Am. Rev. Respir. Dis. 147, 435-441 (1993).
33. S. K. Dower, S. R. Kronheim, T. P. Hopp, M. Cantrell, M. Deeley, S. Gillis, C. S. Henney and D. L. Urdal, The cell surface receptors for interleukin-1 alpha and interleukin-1 beta are identical. Nature 324, 266-268 (1986).
34. R. C. Fuhlbrigge, K. C. Sheehan, R. D. Schreiber, D. D. Chaplin and E. R. Unanue, Monoclonal antibodies to murine IL-1 alpha. Production, characterization, and inhibition of membrane-associated IL-1 activity. J. Immunol. 141, 2643-2650 (1988).
35. 2 production by human synovial cells. J. Clin. Invest. 77, 645-648 (1986).
36. L. S. Constine, S. Harwell, P. Keng, F. Y. Lee, P. Rubin and D. W. Siemann, Interleukin-1 alpha stimulates hemopoiesis but not tumor cell proliferation and protects mice from lethal total body irradiation. Int. J. Radiat. Oncol. Biol. Phys. 20, 447-456 (1991).
37. M. J. Dorie, G. Bedarida and R. F. Kallman, Protection by interleukin 1 against lung toxicity caused by cyclophosphamide and irradiation. Radiat. Res. 128, 316-319 (1991).
38. J. A. Elias, K. Gustilo, W. Baeder and B. Freundlich, Synergistic stimulation of fibroblast prostaglandin production by recombinant interleukin 1 and tumor necrosis factor. J. Immunol. 138, 3812-3816 (1987).
39. D. W. Siemann, P. Rubin and D. P. Penney, Pulmonary toxicity following multi-fraction radiotherapy. Br. J. Cancer 53 (Suppl. VII), 365-367 (1986).
40. H. D. Thames, H. R. Withers, L. J. Peters and G. H. Fletcher, Changes in early and late radiation responses with altered dose fraction: implications for dose-survival relationships. Int. J. Radiat. Oncol. Biol. Phys. 8, 219-226 (1982).
41. D. P. Penney, D. W. Siemann, P. Rubin, D. L. Shapiro and J. N. Finkelstein, Responses of the mouse lung to irradiation. Anat. Rec. 202, 147A (1982). [Abstract]